BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 118816)

  • 21. Prolonged response to succinylcholine: a new variant of plasma cholinesterase that is identified as normal by traditional phenotyping methods.
    Greenberg CP; Primo-Parmo SL; Pantuck EJ; la Du BN
    Anesth Analg; 1995 Aug; 81(2):419-21. PubMed ID: 7618741
    [No Abstract]   [Full Text] [Related]  

  • 22. A rare genetically determined variant of psuedocholinesterase in two German families with high plasma enzyme activity.
    Delbrück A; Henkel E
    Eur J Biochem; 1979 Aug; 99(1):65-9. PubMed ID: 488119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum cholinesterase variants in the Danish population.
    Hanel HK; Viby-Mogensen J; de Muckadell OB
    Acta Anaesthesiol Scand; 1978; 22(5):505-7. PubMed ID: 696214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Polymorphism of plasma cholinesterase in Pyrennees populations. Problems in geographic hematology and pharmacogenetics].
    Vergnes H; Sevin J; Constans J
    Nouv Rev Fr Hematol (1978); 1980; 22(2):105-14. PubMed ID: 7422539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the plasma cholinesterase variants by propranolol.
    Whittaker M; Britten JJ; Wicks RJ
    Br J Anaesth; 1981 May; 53(5):511-6. PubMed ID: 7236476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A practical method for screening atypical pseudocholinesterase.
    Magna LA
    Clin Chim Acta; 1982 Aug; 123(3):333-8. PubMed ID: 7116649
    [No Abstract]   [Full Text] [Related]  

  • 27. Anionic site interactions in human butyrylcholinesterase disrupted by two single point mutations.
    Neville LF; Gnatt A; Padan R; Seidman S; Soreq H
    J Biol Chem; 1990 Dec; 265(34):20735-8. PubMed ID: 2249982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for a single butyrylcholinesterase gene in individuals carrying the C5 plasma cholinesterase variant (CHE2).
    Masson P; Chatonnet A; Lockridge O
    FEBS Lett; 1990 Mar; 262(1):115-8. PubMed ID: 2318303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biochemical polymorphism of serum cholinesterase in populations of the Kurdamir region of the Azerbaijan SSR].
    Gadzhiev BO; Sergeev AS
    Genetika; 1987 Mar; 23(3):549-58. PubMed ID: 2952552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pesticide poisoning, succinylcholine-induced apnea, and pseudocholinesterase.
    Nelson TC; Burritt MF
    Mayo Clin Proc; 1986 Sep; 61(9):750-2. PubMed ID: 3747617
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum atypical pseudocholinesterase and leprosy.
    Navarrete JI; Lisker R; Pérez-Briceńo R
    Int J Dermatol; 1979 Dec; 18(10):822-3. PubMed ID: 528104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An improvement in segregation of human butyrylcholinesterase phenotypes having the fluoride-resistant variants.
    Kovarik Z; Simeon-Rudolf V
    Arh Hig Rada Toksikol; 2003 Dec; 54(4):239-44. PubMed ID: 14994645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinesterase Newfoundland: a new succinylcholine-sensitive variant of cholinesterase at locus 1.
    Simpson NE; Elliott CR
    Am J Hum Genet; 1981 May; 33(3):366-74. PubMed ID: 7246542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genetic and acquired variations in butyrylcholinesterases].
    Leprince A; Josancy M; Allain P; Léonardon P; Martin P
    Cah Anesthesiol; 1985 Nov; 33(7):619-21. PubMed ID: 4092163
    [No Abstract]   [Full Text] [Related]  

  • 35. [A new method for the detection of atypical pseudocholinesterase].
    Magna LA
    Rev Paul Med; 1982; 99(2):8-11. PubMed ID: 7156681
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential inhibition of plasma cholinesterase variants using the dibutyrate analogue of pancuronium bromide.
    Whittaker M; Britten JJ
    Hum Hered; 1981; 31(4):242-7. PubMed ID: 7287015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An explanation for the different inhibitory characteristics of human serum butyrylcholinesterase phenotypes deriving from inhibition of atypical heterozygotes.
    Simeon-Rudolf V; Kovarik Z; Skrinjarić-Spoljar M; Evans RT
    Chem Biol Interact; 1999 May; 119-120():159-64. PubMed ID: 10421449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Butyrylcholinesterase activity and metabolic syndrome in obese patients.
    Alcântara VM; Oliveira LC; Réa RR; Suplicy HL; Chautard-Freire-Maia EA
    Clin Chem Lab Med; 2005; 43(3):285-8. PubMed ID: 15843232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E1h, a new allele at cholinesterase locus 1.
    Whittaker M; Britten JJ
    Hum Hered; 1987; 37(1):54-8. PubMed ID: 3557462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholinesterase: phenotyping and genotyping.
    Goodall R;
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):98-110. PubMed ID: 15025799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.